Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
24.66
-0.11 (-0.44%)
Mar 6, 2026, 4:00 PM EST - Market closed
THNR Holdings List
As of Mar 5, 2026
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 12.05% |
| 2 | NVO | Novo Nordisk A/S | 9.70% |
| 3 | AMGN | Amgen Inc. | 7.70% |
| 4 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 7.58% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 6.79% |
| 6 | TYO: 4507 | Shionogi & Co., Ltd. | 6.24% |
| 7 | MRK | Merck & Co., Inc. | 5.84% |
| 8 | SWX: ROG | Roche Holding AG | 5.59% |
| 9 | LON: AZN | AstraZeneca PLC | 5.45% |
| 10 | ABBV | AbbVie Inc. | 5.16% |
| 11 | PFE | Pfizer Inc. | 5.15% |
| 12 | HKG: 1801 | Innovent Biologics, Inc. | 4.50% |
| 13 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 4.18% |
| 14 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.86% |
| 15 | SRRK | Scholar Rock Holding Corporation | 1.76% |
| 16 | CPH: ZEAL | Zealand Pharma A/S | 1.75% |
| 17 | VKTX | Viking Therapeutics, Inc. | 1.66% |
| 18 | HIMS | Hims & Hers Health, Inc. | 1.56% |
| 19 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 1.30% |
| 20 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 1.03% |
| 21 | JNGHF | Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H | 0.83% |
| 22 | n/a | OTHER ASSETS AND LIABILITIES | 0.30% |
| 23 | n/a | US DOLLARS | 0.01% |
As of Mar 5, 2026